Long-Term Ranibizumab Treatment in Neovascular Age-Related Macular Degeneration: A Belgian Subanalysis from the Global Real-World LUMINOUS(TM) Study

PURPOSE: To evaluate long-term, real-world treatment patterns and outcomes of ranibizumab 0.5 mg for neovascular age-related macular degeneration (nAMD) in a Belgian cohort. PATIENTS AND METHODS: This Belgian (BE) cohort of the 5-year global observational LUMINOUS study included 229 patients with nA...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Ophthalmol
Main Authors: Leys, Anita M, Ramboer, Eva, Favreau, Mérédis, Denhaerynck, Kris, MacDonald, Karen, Abraham, Ivo, Brié, Heidi
Formato: Artigo
Idioma:Inglês
Publicado em: Dove 2020
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7277576/
https://ncbi.nlm.nih.gov/pubmed/32581505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S242547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados